TVRD · Tvardi Therapeutics, Inc. · Webcasts, Transcripts & Audio
$1.00
-0.02 (-1.64%)
At close · Oct 22
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, the Company has concluded that management's plans do not alleviate substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$13.87M
Shares
13.34M
Volume · Oct 22
963
Avg daily vol (3M)
242.64K
Tvardi Therapeutics, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Tvardi Therapeutics, Inc. (TVRD), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Investor Update
Investor event
2026-08-19
Tvardi Therapeutics, Inc. (TVRD) August 19, 2026 Investor Update
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-08-19
Tvardi Therapeutics, Inc. (TVRD) Q2 2026 Earnings Call
Diluted EPS
$-0.69
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-04
Tvardi Therapeutics, Inc. (TVRD) June 4, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY24 · Q1
2024-05-13
Tvardi Therapeutics, Inc. (TVRD) Q1 2024 Earnings Call
Revenue
$2.13M
▼ 65.4% YoY Diluted EPS
$-20.24
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q3
2023-11-13
Tvardi Therapeutics, Inc. (TVRD) Q3 2023 Earnings Call
Revenue
$4.87M
▼ 55% YoY Diluted EPS
$-18.72
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-07
Tvardi Therapeutics, Inc. (TVRD) Q2 2023 Earnings Call
Revenue
$6.93M
▼ 69.9% YoY Diluted EPS
$-20.88
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-15
Tvardi Therapeutics, Inc. (TVRD) Q1 2023 Earnings Call
Revenue
$6.17M
▲ 28.7% YoY Diluted EPS
$-17.64
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-06
Tvardi Therapeutics, Inc. (TVRD) Q4 2022 Earnings Call
Revenue
$3.26M*
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q1
2022-05-09
Tvardi Therapeutics, Inc. (TVRD) Q1 2022 Earnings Call
Revenue
$4.79M
▲ 147.5% YoY Diluted EPS
$-18.72
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q3
2021-11-08
Tvardi Therapeutics, Inc. (TVRD) Q3 2021 Earnings Call
Revenue
$20.27M
▲ 118.8% YoY Diluted EPS
$-0.72
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-09
Tvardi Therapeutics, Inc. (TVRD) Q2 2021 Earnings Call
Diluted EPS
$-21.96
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-10
Tvardi Therapeutics, Inc. (TVRD) Q1 2021 Earnings Call
Revenue
$1.94M
▼ 76.1% YoY Diluted EPS
$-16.92
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-25
Tvardi Therapeutics, Inc. (TVRD) Q4 2020 Earnings Call
Revenue
$112.09M
▲ 2384.8% YoY Diluted EPS
$57.24
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-09
Tvardi Therapeutics, Inc. (TVRD) Q3 2020 Earnings Call
Revenue
$9.27M
▲ 60.2% YoY Diluted EPS
$-12.60
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-10
Tvardi Therapeutics, Inc. (TVRD) Q2 2020 Earnings Call
Revenue
$5.63M
▲ 8.2% YoY Diluted EPS
$-19.44
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-11
Tvardi Therapeutics, Inc. (TVRD) Q1 2020 Earnings Call
Revenue
$8.09M
▲ 84.7% YoY Diluted EPS
$-22.32
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-27
Tvardi Therapeutics, Inc. (TVRD) Q4 2019 Earnings Call
Revenue
$4.51M
▼ 18.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–17 of 17 webcasts